A batch of customized Size 2 gelatin capsules has been successfully loaded and shipped from KornnacCaps's production base, destined for Brazil, a core market in South America. The smooth execution of this export operation marks another substantive breakthrough for KornnacCaps in its international market layout, further solidifying the company's brand position in the global pharmaceutical packaging sector.
As the core deliverable of this international trade transaction, the exported Size 2 gelatin capsules were strictly manufactured in accordance with internationally recognized Good Manufacturing Practices (GMP). During the manufacturing process, KornnacCaps fully leveraged its technical advantages by selecting high-purity pharmaceutical gelatin raw materials. Through precision production processes and a rigorous quality control system, the company ensured that key indicators-such as friability, disintegration time, and elasticity-reached advanced international levels. Prior to leaving the factory, this batch underwent comprehensive testing and demonstrated excellent machine compatibility, perfectly meeting the operational requirements of high-speed fully automatic capsule filling machines and fully satisfying the stringent standards of the Brazilian client for high-quality pharmaceutical empty capsules.
As South America's most influential economy, Brazil boasts a massive pharmaceutical and health supplement market and serves as a strategic battleground for the global pharmaceutical packaging industry. Facing increasingly strict market entry mechanisms and intense competition, KornnacCaps successfully passed the client's multi-dimensional audits and validations by virtue of its stable product quality and efficient supply chain responsiveness. To ensure the smooth implementation of this cross-border delivery, the company's International Trade Department and Logistics Center worked closely together to formulate scientific packaging protection schemes and meticulous logistics plans tailored for long-distance ocean transport, ensuring the cargo arrives at its destination in optimal condition.
The successful shipment of these Size 2 gelatin capsules is a significant achievement for KornnacCaps in implementing its "going global" development strategy and optimizing its global market structure. This not only reflects the high recognition of international clients for the company's product quality and brand reputation but also lays a solid foundation for the subsequent expansion of business in South America and surrounding regions.
Looking ahead, KornnacCaps will continue to uphold the business philosophy of "Quality as the Foundation, Innovation as the Driver" and persist in the R&D and manufacturing of pharmaceutical empty capsules. Taking this as an opportunity, the company aims to further deepen strategic partnerships with international pharmaceutical enterprises, continuously enhance its global supply chain service capabilities, and dedicate itself to providing global customers with superior and safer pharmaceutical packaging solutions, helping the national brand shine on the international stage.
